CRISPR Base Editing Slashes Cholesterol in Monkeys

CRISPR Base Editing Slashes Cholesterol in Monkeys
AP Photo/John Raoux

A form of CRISPR widely expected to be safer and possibly more effective that the original has aced its first substantive test. When CRISPR “base editing” was used to knock out two cholesterol-associated genes in monkeys, the animals' blood levels of heart-disease-causing LDL (“bad”) cholesterol and triglycerides plunged as much as 60% and 65%, respectively, Sekar Kathiresan, co-founder and CEO of Verve Therapeutics, announced on Saturday at the (virtual) meeting of the International Society for Stem Cell Research.

Read Full Article »
Comment
Show comments Hide Comments

Related Articles